Statistics for Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use
Total visits
views | |
---|---|
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use | 4 |
Total visits per month
views | |
---|---|
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 1 |
July 2025 | 0 |
File Visits
views | |
---|---|
DOM-25-407.pdf | 57 |
java.util.UUID:2bb29898-d3b4-4b6c-9de6-8d6dd5b69f08 | 38 |
java.util.UUID:fda22b03-c0e8-423f-8c4b-3c0e05d48331 | 11 |
java.util.UUID:f4ef29b2-c64f-40b7-bcec-1fa9977b6634 | 8 |
Top country views
views | |
---|---|
United States | 3 |
United Kingdom | 1 |
Top city views
views | |
---|---|
Greenwood | 2 |
Bournemouth | 1 |
Indianapolis | 1 |